Cargando…
Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful...
Autores principales: | Anwar, Sirajudheen, Malik, Jonaid Ahmad, Ahmed, Sakeel, Kameshwar, Verma Abhishek, Alanazi, Jowaher, Alamri, Abdulwahab, Ahemad, Nafees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698579/ https://www.ncbi.nlm.nih.gov/pubmed/36431766 http://dx.doi.org/10.3390/molecules27227668 |
Ejemplares similares
-
The evidence for repurposing anti-epileptic drugs to target cancer
por: Aroosa, Mir, et al.
Publicado: (2023) -
Drug Repurposing: A New Hope in Drug Discovery for
Prostate Cancer
por: Malik, Jonaid Ahmad, et al.
Publicado: (2022) -
Association of
SARS-CoV-2 and Polypharmacy
with Gut–Lung Axis: From Pathogenesis to Treatment
por: Malik, Jonaid Ahmad, et al.
Publicado: (2022) -
Editorial: Targeting tumor EMT-related signaling by natural products
por: Anwar, Sirajudheen, et al.
Publicado: (2023) -
Correction to: Understanding translational research in schizophrenia: A novel insight into animal models
por: Malik, Jonaid Ahmad, et al.
Publicado: (2023)